Australian women with aggressive form of advanced breast cancer now have …
Perjeta is now approved in combination with the targeted therapy, Herceptin® (trastuzumab), and the chemotherapy, docetaxel, for the treatment of women with advanced HER2-positive breast cancer who have not received prior treatment (either anti-HER2 … Read more on The International News Magazine
Blood Test Predicts Which Bipolar Patients Will Respond to Ketamine
“But one in three patients do not respond to this treatment. This research will help … “The next step is to look for the genetic or environmental factors that determine whether a person develops the metabolic pattern that responds to the treatment … Read more on PsychCentral.com